April 7 marks World Health Day. This year’s global focus is on diabetes – scaling up prevention, strengthening care, and enhancing surveillance. As the World Health Organization (WHO) notes, the rate of people living with diabetes has grown by almost 400% since 1980 and will likely double over the next two decades. 422 million people across the world live with diabetes, and by 2030 diabetes is projected to be the 7th most likely cause of death globally.
Deaths from diabetes disproportionately effect low- and middle-income countries, in large part due to the lack of medicines and technologies necessary for management. When diabetes is detected early and managed well, diabetes patients are able to live long, healthy lives. Tired of expensive, difficult-to-follow regimens for treatment and lifestyle changes, patients around the world are pushing for technologies and treatments to better manage diabetes.
SERMO asked 1359 doctors from Argentina, Australia, Canada, Denmark, New Zealand, and the United States, representing over 35 specialties, about their thoughts on the future of diabetes treatment. When asked which advances in treatments hold the most promise for patients:
- 44 percent of doctors polled felt stem cell implantation therapies to promote insulin production were the most promising
- 28 percent have the most faith in advances in multi-drug treatment courses; research that produces clearer best practices for treating diabetes with multiple medications, including Metformin and others
- 19 percent of doctors pointed to generic insulin, priced lower than branded products, as the most promising advancement for patients
- 9 percent felt that upgrading blood sugar monitors, so measurements are accessible to caregivers and health care professionals via the cloud could most strongly benefit patients